These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39083978)
1. PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma. Lin Y; Liu J; Chen S; Wu Q; Shen F; Gan L Biochem Biophys Res Commun; 2024 Nov; 734():150338. PubMed ID: 39083978 [TBL] [Abstract][Full Text] [Related]
2. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
3. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma. Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266 [TBL] [Abstract][Full Text] [Related]
4. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
5. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
6. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM). Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma. Liao L; Han W; Shen Y; Shen G J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and immune infiltration implications of SIGLEC9 in SKCM. Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970 [TBL] [Abstract][Full Text] [Related]
9. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Liu X; Wang J Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma. Wu X; Chen S; Ji Q; Chen H; Chen X Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879 [TBL] [Abstract][Full Text] [Related]
11. Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma. Han W; Shen GL Int Immunopharmacol; 2020 Nov; 88():106958. PubMed ID: 33182068 [TBL] [Abstract][Full Text] [Related]
12. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
13. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients. Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil extracellular trap related risk score exhibits crucial prognostic value in skin cutaneous melanoma, associating with distinct immune characteristics. Zhang H; Bi X; Yan P; Wang C Skin Res Technol; 2024 Aug; 30(8):e70008. PubMed ID: 39167030 [TBL] [Abstract][Full Text] [Related]
16. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma. Jiang Y; Zhang C; Zhang J; Han D; Shi X Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233 [TBL] [Abstract][Full Text] [Related]
18. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM. Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y Front Immunol; 2024; 15():1387316. PubMed ID: 38660305 [TBL] [Abstract][Full Text] [Related]
19. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. Long S; Xu J; Huang H Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280 [TBL] [Abstract][Full Text] [Related]
20. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma. Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]